title: Microbiology. Exploiting malaria drug resistance to our advantage.
authors.affiliation: GlaxoSmithKline, Madrid, 28760 Spain. nicholas.c.cammack@gsk.com
authors.forename: Nick
authors.initials: N
authors.lastname: Cammack
mesh_terms: D000962:Antimalarials / Q000494:pharmacology*; D005075:Biological Evolution; D004338:Drug Combinations; D004351:Drug Resistance / Q000235:genetics; D017125:Genes, Protozoan; D008040:Genetic Linkage; D018503:Genome, Protozoan; D055106:Genome-Wide Association Study; D057166:High-Throughput Screening Assays; D021261:Parasitic Sensitivity Tests; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism
chemical_list: D000962:Antimalarials; D004338:Drug Combinations